Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 48, 2018 - Issue 9
1,914
Views
5
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Extrapolation of plasma clearance to understand species differences in toxicokinetics of bisphenol A

&
Pages 891-897 | Received 30 Jun 2017, Accepted 11 Sep 2017, Published online: 13 Oct 2017

References

  • Arnich N, Canivenc-Lavier M-C, Kolf-Clauw M, et al. (2011). Conclusions of the French Food Safety Agency on the toxicity of bisphenol A. Int J Hyg Environ Health 214:271–5
  • Barrett JR. (2011). The pharmacokinetics of BPA: similarities in human and animal metabolism suggest higher exposure than thought. Environ Health Perspect 119:A177
  • Clewell HJ, Andersen ME, Barton HA. (2002). A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environ Health Perspect 110:85–93
  • Cornish HH, Ryan RC. (1965). Metabolism of benzene in nonfasted, fasted, and aryl-hydroxylase inhibited rats. Toxicol Appl. Pharmacol 7:767–71
  • Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW. (2010a). Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicol Appl Pharmacol 247:158–65
  • Doerge DR, Twaddle NC, Woodling KA, Fisher JW. (2010b). Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Toxicol Appl Pharmacol 248:1–11
  • Doerge DR, Vanlandingham M, Twaddle NC, Delclos KB. (2010c). Lactational transfer of bisphenol A in Sprague-Dawley rats. Toxicol Lett 199:372–6
  • Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW. (2011). Pharmacokinetics of bisphenol A in neonatal and adult CD-1 mice: inter-species comparisons with Sprague-Dawley rats and rhesus monkeys. Toxicol Lett 207:298–305
  • Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW. (2012). Pharmacokinetics of bisphenol A in serum and adipose tissue following intravenous administration to adult female CD-1 mice. Toxicol Lett 211:114–19
  • Domoradzki JY, Thornton CM, Pottenger LH, et al. (2004). Age and dose dependency of the pharmacokinetics and metabolism of bisphenol A in neonatal sprague-dawley rats following oral administration. Toxicol Sci 77:230–42
  • EFSA (European Food Safety Authority). (2015). Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs: PART II - Toxicological assessment and risk characterisation. EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) European Food Safety Authority (EFSA), Parma, Italy. http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/3978part2.pdf
  • FDA: Roth WL, Komolprasert V. (2007). Toxicokinetics of Bisphenol A. Memo to US Department of Health and Human services. https://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-0038b1_01_16_FDA%20 Reference%20Material-FDA%20Memo%20FDA%20Memo%20P.pdf
  • Foureman GL, Kenyon EM. (2006). Harmonization in interspecies extrapolation: use of BW3/4 as default method in derivation of the oral RfD. EPA/630/R-06/001. Washington (DC)
  • Gentry PR, Covington TR, Andersen ME, Clewell HJ. (2002). Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol. Pharmacol 36:51–68
  • Hengstler JG, Foth H, Gebel T, et al. (2011). Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol 41:263–91
  • Kirman CR, Sweeney LM, Meek ME, Gargas ML. (2003). Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling. Regul Toxicol Pharmacol 38:345–67
  • Lagarde F, Beausoleil C, Belcher SM, et al. (2015). Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment. Environ Health 14:13
  • Motulsky HJ, Brown RE. (2006). Detecting outliers when fitting data with nonlinear regression – a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinformatics 7:123
  • Murray TJ, Maffini MV, Ucci AA, et al. (2007). Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol 23:383–90
  • Negishi T, Tominaga T, Ishii Y, et al. (2004). Comparative study on toxicokinetics of bisphenol A in F344 rats, monkeys (Macaca fascicularis), and chimpanzees (Pan troglodytes). Exp Anim 53:391–4
  • NTP. (2008). NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. Washington, DC
  • NTP. (2010). Bisphenol A. Washington (DC)
  • Peretz J, Vrooman L, Ricke WA, et al. (2014). Bisphenol A and reproductive health: update of experimental and human evidence, 2007–2013. Environ Health Perspect 122:775–86
  • Pottenger LH, Domoradzki JY, Markham DA, et al. (2000). The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 54:3–18
  • Salian S, Doshi T, Vanage G. (2009a). Perinatal exposure of rats to bisphenol A affects the fertility of male offspring. Life Sci 85:742–52
  • Salian S, Doshi T, Vanage G. (2009b). Impairment in protein expression profile of testicular steroid receptor coregulators in male rat offspring perinatally exposed to bisphenol A. Life Sci 85:11–18
  • Sieli PT, Jašarevic E, Warzak DA, et al. (2011). Comparison of serum bisphenol A concentrations in mice exposed to bisphenol A through the diet versus oral bolus exposure. Environ Health Perspect 119:1260–5
  • Stump DG, Beck MJ, Radovsky A, et al. (2010). Developmental neurotoxicity study of dietary bisphenol A in Sprague-Dawley rats. Toxicol Sci 115:167–82
  • Taylor J. (2011). Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect. 119:422–30
  • Teeguarden JG, Hanson-Drury S. (2013). A systematic review of bisphenol A “low dose" studies in the context of human exposure: a case for establishing standards for reporting “low-dose" effects of chemicals. Food Chem Toxicol 62:935–48
  • Teeguarden JG, Twaddle NC, Churchwell MI, et al. (2015a). 24-hour human urine and serum profiles of bisphenol A following ingestion in soup: Individual pharmacokinetic data and emographics. Data Brief 4:83–6
  • Teeguarden JG, Twaddle NC, Churchwell MI, et al. (2015b). 24-hour human urine and serum profiles of bisphenol A following ingestion in soup: individual pharmacokinetic data and emographics. Data Brief 4:83–6
  • Thayer KA, Doerge DR, Hunt D, et al. (2015). Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ Int 83:107–15
  • Tominaga T, Negishi T, Hirooka H, et al. (2006). Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/MS method. Toxicology 226:208–17
  • Vandenberg LN, Gerona RR, Kannan K, et al. (2014). A round robin approach to the analysis of bisphenol A (BPA) in human blood samples. Environ Health 13:25
  • Vogel SA. (2009). The politics of plastics: the making and unmaking of bisphenol a “safety". Am J Public Health 99:S559–66
  • Völkel W. (2017). Why did researchers not use realistic doses in animal studies of bisphenol A? Arch Toxicol 91:1519–22
  • Völkel W, Colnot T, Csanády GA, et al. (2002). Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol 15:1281–7
  • Yang X, Fisher JW. (2014). Unraveling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling. Front Pharmacol 5:292
  • Zoeller RT, Vandenberg LN. (2015). Assessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity. Environ Health 14:42